Dabuzalgron
Dabuzalgron (Ro 115-1240) is a selective α1A-adrenoceptor agonist used in research for urinary incontinence. Studies indicate it also exhibits a cardioprotective role in models of doxorubicin-induced cardiotoxicity by preserving mitochondrial function, relevant for in vivo and in vitro pharmacological investigations.
Product Specifications
CAS Number
219311-44-1
Product Name Alternative
Dabuzalgron, Cell, Beta Receptor, AdrenergicReceptor, Adrenergic Receptor, Apoptosis, mitochondrial, inhibit, incontinence, death, Inhibitor, membrane, α1A-adrenergic receptor, urinary, Ro 115-1240, potential
Field of Research
Cell Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.35% (May vary between batches)
Solubility
DMSO:25 mg/mL (78.67 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.29 mM)
Smiles
Cc1c (OCC2=NCCN2) ccc (Cl) c1NS (C) (=O) =O
Molecular Formula
C12H16ClN3O3S
Molecular Weight
317.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
